Results
|
15781.
|
|
|
15782.
|
|
|
15783.
|
|
|
15784.
|
|
|
15785.
|
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. [electronic resource] by
- Min, H
- Morony, S
- Sarosi, I
- Dunstan, C R
- Capparelli, C
- Scully, S
- Van, G
- Kaufman, S
- Kostenuik, P J
- Lacey, D L
- Boyle, W J
- Simonet, W S
Producer: 20010322
In:
The Journal of experimental medicine vol. 192
Availability: No items available.
|
|
15786.
|
|
|
15787.
|
|
|
15788.
|
|
|
15789.
|
|
|
15790.
|
|
|
15791.
|
|
|
15792.
|
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. [electronic resource] by
- Burgess, T L
- Qian, Y
- Kaufman, S
- Ring, B D
- Van, G
- Capparelli, C
- Kelley, M
- Hsu, H
- Boyle, W J
- Dunstan, C R
- Hu, S
- Lacey, D L
Producer: 19990601
In:
The Journal of cell biology vol. 145
Availability: No items available.
|
|
15793.
|
|
|
15794.
|
|
|
15795.
|
|
|
15796.
|
|
|
15797.
|
|
|
15798.
|
|
|
15799.
|
|
|
15800.
|
|